Experience with the 'Triple Test' in pancreatic disease.
The results of the secretin-pancreozymin test, duodenal aspirate cytology and hypotonic duodenography (the Triple Test), performed during a single duodenal intubation in patients with pancreatic or ampullary carcinoma, chronic pancreatitis and non-pancreatic disease were analysed retrospectively. Thirty-five of 36 carcinoma patients and all 11 chronic pancreatitis patients had an abnormal result. One hundred and sixteen of 170 non-pancreatic disease patients had a normal result. It would appear that the Triple Test (TT) may be a useful screening test for pancreatic disease.
D002766:Cholecystokinin; D002908:Chronic Disease; D004386:Duodenum / Q000000981:diagnostic imaging; D006801:Humans; D007419:Intestinal Secretions / Q000166:cytology; D007441:Intubation, Gastrointestinal; D010182:Pancreatic Diseases / Q000175:diagnosis*; D010186:Pancreatic Function Tests; D010190:Pancreatic Neoplasms / Q000175:diagnosis; D010195:Pancreatitis / Q000175:diagnosis; D011859:Radiography; D012189:Retrospective Studies; D012633:Secretin
D012633:Secretin; D002766:Cholecystokinin